PMC:7441788 / 4622-5112
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T47 | 86-104 | Disease | denotes | SARS-CoV infection | http://purl.obolibrary.org/obo/MONDO_0005091 |
T48 | 95-104 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T49 | 287-296 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T40 | 15-21 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
T41 | 234-239 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T42 | 261-267 | http://purl.obolibrary.org/obo/CLO_0001751 | denotes | and 33 |
T43 | 313-315 | http://purl.obolibrary.org/obo/CLO_0001527 | denotes | 94 |
T44 | 349-354 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T45 | 445-446 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T56 | 48-50 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T57 | 138-140 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T58 | 203-205 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T59 | 330-332 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T60 | 427-436 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T61 | 471-473 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T36 | 48-50 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T37 | 138-140 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T38 | 203-205 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T39 | 330-332 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T40 | 471-473 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T46 | 86-94 | Species | denotes | SARS-CoV | NCBItxid:694009 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T40 | 0-490 | Sentence | denotes | Vincent et al. tested various concentrations of CQ (0.1–10 µM) added 20–24 h prior to SARS-CoV infection and found that 0.1, 1, and 10 µM CQ reduced infectivity by 28%, 53%, and 100%, respectively; when CQ was added immediately after virus adsorption, 0.1–1 µM and 33–100 µM reduced the infection by 50% up to 90–94%; addition of CQ 3 and 5 h after virus adsorption was still significantly effective, yet to achieve equivalent antiviral effect, a higher concentration of CQ was needed [13]. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
212 | 86-104 | Disease | denotes | SARS-CoV infection | MESH:C000657245 |
213 | 287-296 | Disease | denotes | infection | MESH:D007239 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T34 | 95-104 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infection |
T35 | 149-160 | http://purl.obolibrary.org/obo/IDO_0000464 | denotes | infectivity |
T36 | 234-239 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T37 | 287-296 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infection |
T38 | 349-354 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T39 | 427-436 | http://purl.obolibrary.org/obo/IDO_0000559 | denotes | antiviral |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T41 | 86-104 | Disease | denotes | SARS-CoV infection | http://purl.obolibrary.org/obo/MONDO_0005091 |
T42 | 287-296 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
212 | 86-104 | Disease | denotes | SARS-CoV infection | MESH:C000657245 |
213 | 287-296 | Disease | denotes | infection | MESH:D007239 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T40 | 0-490 | Sentence | denotes | Vincent et al. tested various concentrations of CQ (0.1–10 µM) added 20–24 h prior to SARS-CoV infection and found that 0.1, 1, and 10 µM CQ reduced infectivity by 28%, 53%, and 100%, respectively; when CQ was added immediately after virus adsorption, 0.1–1 µM and 33–100 µM reduced the infection by 50% up to 90–94%; addition of CQ 3 and 5 h after virus adsorption was still significantly effective, yet to achieve equivalent antiviral effect, a higher concentration of CQ was needed [13]. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32496926-16115318-132195660 | 486-488 | 16115318 | denotes | 13 |